Sponsored ContentAlways Pure Organics: A Focus on Novel Foods

Always Pure Organics: A Focus on Novel Foods


Sponsored content with Always Pure Organics

NOVEL Foods continues to be the main talking point in the UK CBD industry, and for good reason. It is, without a doubt, the fulcrum upon which the future of the market balances.

Always Pure Organics.

Decisions made by both the regulatory bodies and market participants now will have rippling effects in the future for both the UK and EU markets, and likely even further afield. 

What products can be sold, how they can be marketed and the allowed levels of various substances in them are all yet to be determined. There is also the inevitable changes in market share as some companies find their products non-viable while others enjoy a relative lack of competition on certain bespoke products. 

Regardless of the final outcome, we at Always Pure Organics are determined to maintain our position as a market leader in the UK. To this end, we have applied for Novel Foods status for three products, a Swiss Isolate, a Colombian Isolate and a Colombian Broad-Spectrum Distillate. 

Exciting And Varied CBD Products

When it comes to product range, we hope that the information we have submitted to the FSA will ensure that we can offer a considerable number of exciting and varied CBD products. 

From capsules to gummies, Isolate oils to terpene-flavoured Broad-Spectrum oral drops, we hope the broad range will be able to cater to any requirement our clients may have. Our product range even includes brands that are designed as entry products for smaller businesses, or even for larger companies that wish to ‘try the waters’ without committing to going through the full application process. 

As these products are not created on behalf of a specific client of ours, we can offer them to anyone wishing to establish a presence in the CBD market, which is likely to benefit those who are unable to afford a full application themselves. We feel that this ability to support smaller businesses is crucial in maintaining the charm and intimacy that the CBD industry has thrived on prior to the Novel Foods announcement.  

On top of specialised product ranges for clients that either don’t want to or can’t afford to produce their own brands, APO also handles the regulatory requirements for our existing customers so they don’t have to worry about the administrative work necessary to stay on the market. 

While we can’t guarantee that everything will pass first time, we are confident that any concerns the FSA may have will be easily addressed. 

Due Diligence

Our dossiers have been crafted through the assistance of toxicology, analytical and regulatory experts and as such we have the utmost faith that we can meet any requests for additional information that the FSA may present. 

Part of our process included a full overview of the production process for both raw materials and finished products as well as in-depth compositional analysis that looks at levels of hundreds of potential contaminants and impurities. 

The toxicology sections of our dossiers have been diligently complied by DevelRx, a company with considerable expertise in both toxicology and cannabinoids, making them the perfect choice to prove the safety of CBD. 

Finally, there are of course a good number of products that do not require Novel Foods authorisation at all. We are particularly proud of our high-quality cosmetics, fully registered on the CPNP, with options such as blood-orange or lavender lotion, menthol balm or tattoo repair-cream. We work closely with cosmetic formulation experts to include ingredients proven to have beneficial effects that pair well with the natural benefits of CBD, allowing us to make legal claims as to their benefits. In addition, we offer vapeable solutions and have been investing into further product research in this category to develop a portfolio capable of satisfying any potential clients. 

While Novel Foods presents considerable financial and administrative hurdles for anyone wishing to compete within the CBD market, the improvements to regulation and market confidence are going to be welcome developments. Always Pure Organics fully intends to be at the forefront of however the industry develops into and we believe that our dedication to quality and reliability, combined with the range of products we can offer post-Novel Foods and our ability to support smaller clients, will provide the perfect environment to allow us to maintain this position. 

Andrew Megahy.

By Andrew Megahy, Chief Scientific Officer – Always Pure Organics

Always Pure Organics, A Specialist Manufacturer of Cannabis Based Products.

We offer the highest quality wholesale legal cannabis and cannabinoid products, as bulk ingredients, bulk products, white label, and bespoke formulations. This is coupled with regulatory and legal expertise and supported by delivery globally.

Our unique bespoke formulation products allow our customers to create their own product from scratch, whilst we provide the regulatory and product knowledge, as well as production of the product.

To find out more about how Always Pure Organics can support your business on its CBD journey visit alwayspureorganics.com or follow us on LinkedIn.

Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.


Please enter your comment!
Please enter your name here

Latest news

Germany’s ‘KanaVape’ Moment As Police And Courts Crackdown On ‘Narcotic’ Hemp & CBD

TWO senior figures in the European cannabis industry are leading the fight against over-zealous German law enforcement in a...

UK CBD Consumption To Switch From Oils To Capsules – As New Research Estimates Market Value At £690m

CAPSULES are set to replace oils as the preferred method of CBD consumption - as new research show the...

Crowdfunding: An Emerging Capital Greenhouse For The Cannabis Industry

ALPHAGREEN is expected to hit close to the £2m crowdfunding mark on the Seedrs platform by mid-May – double...

Former JP Morgan Banker Lands Two UK Cannabis Jobs

A VETRAN of American investment bank JP Morgan has entered the burgeoning field of cannabis with appointments to two...

Europe’s Hemp Pioneer Posts Record Results With CBD, Construction And Car-Making To The Fore

EUROPEAN pioneer HempFlax has posted record annual results with revenues up 43% to €14.5m (£12.5m) as it returned a...

Sales Up Sharply At Sativa Wellness But Operational Costs Lead to £4.5m Loss

BRITISH CBD firm Sativa Wellness saw annual sales rise by over one-third in an eventful year which saw it...

Must read

Germany’s ‘KanaVape’ Moment As Police And Courts Crackdown On ‘Narcotic’ Hemp & CBD

TWO senior figures in the European cannabis industry are...

You might also likeRELATED
Recommended to you